Roche Xenical Patient Compliance Could Increase With New DTC Campaign
Executive Summary
Roche will attempt to increase patient compliance for its obesity drug Xenical through a multi-faceted direct-to-consumer campaign.
You may also be interested in...
Roche Xenical Patient Retention Program Is Key To Sales Growth
Roche has set up a Xenical patient retention program in the U.S. in a continuing effort to improve the obesity drug's sales record.
Roche Xenical Patient Retention Program Is Key To Sales Growth
Roche has set up a Xenical patient retention program in the U.S. in a continuing effort to improve the obesity drug's sales record.
Roche U.S. CEO Zenner Retiring In January; Successor Not Yet Named
Roche is varying from its decades long pattern of carefully choreographed management transitions by leaving open the succession plan for U.S. CEO Patrick Zenner.